Pune, India -- (SBWire) -- 10/15/2018 --Market Scenario:
Eye cancers or ocular cancers manifests itself in the eye. Cancer is referred to the uncontrolled growth of the cells, similarly, eye cancer occurs when healthy cells in or around the eye change and grow uncontrollably leading to the formation of tumors. The global eye cancer market is expecting a healthy growth in coming future. The global market is majorly driven by increasing eye cancer patients across the globe. Additionally, increasing smoking population and rising consumption of alcohol have spurred the growth of the market. However, long time for approval, and side effects of the treatment may hinder the growth of the market.
Get Sample Copy @ https://www.marketresearchfuture.com/sample_request/4736
The global eye cancer market is expected to grow at a CAGR of ~8.3 % during the forecast period 2017-2023.
Key Players
Some of key the players in the market are Novartis AG (Switzerland), Spectrum Pharmaceuticals Inc. (U.S.), GlaxoSmithKline Plc. (U.K.),Bayer AG (Germany), Amgen, Inc. (U.S.), Bristol-Myers Squibb Company (U.S.), Eli Lilly and Company (U.S.), AstraZeneca Plc. (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Janssen Biotech, Inc. (U.S.), Sanofi (France), AbbVie Inc. (U.S.), Takeda Pharmaceuticals (Japan), Pfizer, Inc. (U.S.), Merck & Co., Inc. (U.S.), Oncomed Pharmaceuticals (U.S.) and Immunomedics (U.S.).
Segmentation
The global eye cancer market is segmented on the basis of types, treatment and end users.
On the basis of types, the market is segmented into intraocular cancer, squamous cell cancer, rhabdomyosarcoma, and others. Intraocular cancer is further segmented into melanoma of the eye, lymphoma of the eye, and eye cancers in children.
On the basis of treatment, the market is categorised into chemotherapy, surgery & radiation therapy, targeted therapy, hormone therapy, biologic therapy, and other. Chemotherapy is further segmented into anthracyclines, taxanes, antimetabolites, and alkylating agents. Target therapy is sub segmented into monoclonal antibodies and tyrosine kinase inhibitors. Hormone therapy is further segmented into selective estrogen-receptor modulators (SERMs), aromatase inhibitors and others.
On the basis of end users, the market is segmented into hospital & clinics, ambulatory care centers and others.
Apply for Exclusive Discount @ https://www.marketresearchfuture.com/check-discount/4736
Table Of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power Of Suppliers
5.1.2 Bargaining Power Of Buyers
5.1.3 Threat Of New Entrants
5.1.4 Threat Of Substitutes
5.1.5 Intensity Of Rivalry
Send An Enquiry @ https://www.marketresearchfuture.com/enquiry/4736
About Market Research Future
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Global Eye Cancer Market Research Report by Type-Intraocular Cancer, Squamous Cell Cancer, Rhabdomyosarcoma, by Treatment and End User with Application Analysis, Regional
Global Eye Cancer Market Research Report, By Type (Intraocular Cancer, Squamous Cell Cancer, Rhabdomyosarcoma), Treatment (Chemotherapy, Targeted Therapy, Surgery & Radiation Therapy, Hormone Therapy), End User (Hospital & Clinics) - Forecast till 2023